Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |